Assessment of the clinical outcome of a symptom-based outpatient hyperglycemia protocol

Diabetes Therapy

Volumn 2, Issue 2, 2011, Pages 67-80

  Armor, Becky ^a   Harrison, Don ^a   Lawler, Frank ^b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF PHARMACY   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

ambulatory care; chronic care model; diabetes mellitus; hyperglycemia; outpatient appointments; protocol

Indexed keywords

CARBON DIOXIDE; CHLORIDE; CREATININE; GLUCOSE; INSULIN; NITROGEN; POTASSIUM; SODIUM; UREA;

ACUTE DISEASE; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CREATININE BLOOD LEVEL; DIABETES EDUCATION; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HYDRATION; HYPERGLYCEMIA; HYPEROSMOLARITY; LABORATORY TEST; MALE; OUTCOME ASSESSMENT; OUTPATIENT; OUTPATIENT CARE; PRIORITY JOURNAL; TREATMENT FAILURE; UREA NITROGEN BLOOD LEVEL;

EID: 79955939131     PISSN: 18696953     EISSN: 18696961     Source Type: Journal    
DOI: 10.1007/s13300-011-0001-4     Document Type: Article

References (16)

1. Dall T, Mann SE, Zhang Y, Martin J, Chen Y, Hogan P, of The Lewin Group. ADA Position Statement. Economic costs of diabetes in the US in 2007. Diabetes Care. 2008; 31: 1-20.
2. Wilper AP, Woolhandler S, Lasser KE, et al. Waits to see an emergency department physician: U. S. trends and predictors, 1997-2004. Health Affairs. 2008; 27: w84-w95.
3. American Diabetes Association Clinical Practice Recommendations. Hyperglycemic crises in diabetes. Diabetes Care. 2004; 27(suppl. 1): S94-S102.
4. Della Manna T, Steinmetz L, Campos PR, et al. Subcutaneous use of a fast-acting insulin analog: an alternative treatment for pediatric patients with diabetic ketoacidosis. Diabetes Care. 2005; 28: 1856-1861.
5. Umpierrez GE, Latif K, Stoever J, et al. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. Am J Med. 2004; 117: 291-296.
6. Umpierrez GE, Cuervo R, Karabell A, Latif K, Freire AX, Kitabchi AE. Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care. 2004; 27: 1873-1878.
7. Umpierrez GE, Kelly JP, Navarrete JE, Casals MM, Kitabchi AE. Hyperglycemic crises in urban blacks. Arch Int Med. 1997; 157; 669-675.
8. Maldonado MR, Chong ER, Oehl MA, Balasubramanyam A. Economic impact of diabetic ketoacidosis in a multiethnic indigent population. Analysis of cost based on the precipitating cause. Diabetes Care. 2003; 26; 1265-1269.
9. StataCorp. Stata statistical software [computer program]. Version 10. College Station, TX: StataCorp LP; 2007.
10. American Medical Association. Current Procedural Terminology 2010. Professional Edition. Minneapolis, MN: Ingenix Inc.; 2009.
11. American Diabetes Association Clinical Practice Recommendations. Hyperglycemic crises in diabetes. Diabetes Care. 2004; 27(Suppl. 1): S94-S102.
12. DeFronzo R, Matsuda M, Barrett E. Diabetic ketoacidosis: a combined metabolic-nephrologic approach to therapy. Diabetes Rev. 1994; 2: 209-238.
13. Kitabchi A, Fisher JN, Murphy MB, Rumbak MJ. Diabetic ketoacidosis and the hyperglycemic, hyperosmolar nonketotic state. In: Joslin's Diabetes Mellitus. 13th edition. Philadelphia, PA: Lea and Febiger; 1994: 739-765.
14. Kitabchi A, Umpierraz G, Murphy M, et al. Management of hyperglycemic crises in patients with diabetes. Diabetes Care. 2001: 24; 131-153.
15. Kreisberg R. Diabetic ketoacidosis. In: Diabetes Mellitus: Theory and Practice. 4th edition. New York: Elsevier Science; 1990: 591-603.
16. Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009; 32: 1335-1343.